undamentalytics Newsletter

BGM Group Ltd. income statement

In fiscal 2025, BGM Group Ltd. reported revenue of $37.9m, up 51.1% on the year before, operating income of −$12.6m (a -33.2% margin) and net income of −$19.9m, or −$0.18 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

BGM Group Ltd.: income statement, annual
Fiscal year2018Sept 20182019Sept 20192020Sept 20202021Sept 20212022Sept 20222023Sept 20232024Sept 20242025Sept 2025
Revenue5046505765462538
Cost of revenue4236425159452132
Gross profit810866246
Research and development—0001111
Selling, general and administrative243344318
Operating income66522−3−1−13
Interest expense0000————
Net interest income——−0−000——
Income before tax67632−8−2−20
Income tax111000−10
Net income56531−8−1−20
Diluted EPS$0.06$0.06$0.06$0.03$0.01−$0.07−$0.01−$0.18
Diluted shares (average)90m90m90m102m108m108m108m113m
EBITDA77643−11−11

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BGM vs IMCCBGM vs CPIXBGM vs SBFM

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from BGM Group Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to BGM Group Ltd.